Price $28.35 |
Market Cap
184M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
9.8
|
P/B
2.63
|
P/S
2.39
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
13.5
|
Op. Cash Flow
15.7K
|
FCF
2.0
|
|
Op. Margin
23.40%
|
Net Margin
24.80%
|
ROE
31.00%
|
ROI
32.80%
|
|
ROA
21.40%
|
EPS Growth
32.10%
|
Current Ratio
2.2
|
Debt/Equity
4.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $17.50 | - | - | 5.89B | Strong Buy |
| MGC Diagnostics Corp (MGCD) | $8.40 | - | - | 37.3M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.95 | - | - | 5.8M | Strong Buy |
| Birner Dental Mgmt Services In (BDMS) | $12.75 | - | 6.50% | 25.1M | Strong Buy |
| Genesis Healthcare Inc (GEN) | $1.44 | - | - | 265.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
